Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC News
- Adult Immunization
- Hepatology
- Rare Disorders
- Pediatric Immunization
- Weight Management
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Kidney Disease
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Orthopedics
- Obesity Medicine
- Rheumatology
- Technology
- Oncology
- Nephrology
- Neurology
- Pulmonology
NEW: NIH COVID-19 Treatment Guideline Update 7-8-2021
The most recent update to NIH COVID-19 Treatment Guidelines incorporates RCT data on use of antivirals, immunomodulators, and colchicine as treatment for SARS-CoV-2 infection.
The National Institutes of Health (NIH) on July 8, 2021, published a revised version of the "living" Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.
Updates are made regularly based on availability for review by the COVID-19 Treatment Guidelines Panel (the Panel) of new data related to assessment and general and therapeutic management of persons at risk for or diagnosed as having infection with SARS-CoV-2.
Following are highlights of major changes made to the guidelines within the last month.
Related Videos
Related Content
